Browse Pet Safety Reports
18,045 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,045 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,045 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Aug 26, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Hives (see also Skin); Oedema NOS (see other SOCs for specific oedemas); Skin... | Ongoing |
| Aug 22, 2024 | Horse | Crossbred Equine/horse, Morgan | Diclazuril Oral Pellets | Recumbency; Behavioural disorder NOS | Recovered/Normal |
| Aug 22, 2024 | Horse | Morgan, Morgan | Pentosan Polysulfate Sodium | Injection site alopecia | Recovered/Normal |
| Aug 22, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Aug 21, 2024 | Horse | Holsteiner | Flunixin Meglumine Injectable | Trembling; Injection site pain | Recovered/Normal |
| Aug 21, 2024 | Horse | Horse (unknown) | Monensin Sodium | Sudden death; Accidental exposure | Died |
| Aug 21, 2024 | Horse | Pony (unspecified) | Ceftiofur Crystalline Free Acid | Injection site swelling; Injection site pain | Ongoing |
| Aug 21, 2024 | Horse | Holsteiner | Ceftiofur Crystalline Free Acid | Trembling; Injection site pain | Recovered/Normal |
| Aug 20, 2024 | Horse | Horse (unknown) | Firocoxib | Lack of efficacy (virus) - rotavirus | Outcome Unknown |
| Aug 19, 2024 | Horse | Welsh Pony | Pentosan Polysulfate Sodium | Injection site swelling; Behavioural disorder NOS; Irritability; Agitation; G... | Ongoing |
| Aug 19, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lethargy (see also Central nervous system depression in Neurological); Anorexia | Recovered/Normal |
| Aug 19, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Aug 19, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 19, 2024 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Hives (see also Skin); Hypersensitivity reaction | Ongoing |
| Aug 16, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Death by euthanasia; Lack of efficacy - NOS | Euthanized |
| Aug 16, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Aug 15, 2024 | Horse | Arab | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Aug 15, 2024 | Horse | Trakehner | Pentosan Polysulfate Sodium | Muscle stiffness; Fasciculation | Recovered/Normal |
| Aug 15, 2024 | Horse | Warmblood (unspecified) | Flunixin Meglumine Injectable | Death by euthanasia; Diarrhoea; Inappetence; Digestive tract hypermotility; I... | Euthanized |
| Aug 15, 2024 | Horse | Hanovarian, Paint | Pentosan Polysulfate Sodium | Injection site hair change; Injection site hair loss; Injection site reddenin... | Recovered/Normal; Outcome Unknown |
| Aug 14, 2024 | Horse | Friesian | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Aug 13, 2024 | Horse | Unknown | Pentobarbital Sodium And Phenytoin So... | Lack of efficacy - NOS; Death by euthanasia; Abnormal breathing | Euthanized |
| Aug 13, 2024 | Horse | Horse (unknown) | Ceftiofur Crystalline Free Acid | Injection site swelling; Intentional misuse | Ongoing |
| Aug 13, 2024 | Horse | Warmblood - Dutch | Flunixin Meglumine Injectable | Polyuria; Polydipsia; Quiet; Lethargy (see also Central nervous system depres... | Ongoing |
| Aug 13, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling | Outcome Unknown |
| Aug 13, 2024 | Horse | Warmblood - Dutch | Clodronate Disodium | Polyuria; Polydipsia; Quiet; Lethargy (see also Central nervous system depres... | Outcome Unknown |
| Aug 12, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Hives (see also Skin) | Outcome Unknown |
| Aug 12, 2024 | Horse | Arab | Detomidine Hydrochloride | Maternal aggression to offspring; Not himself/herself | Outcome Unknown |
| Aug 12, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy (bacteria) - Borrelia | Outcome Unknown |
| Aug 12, 2024 | Horse | Horse (unknown) | Detomidine Hydrochloride | Sedation prolonged | Recovered/Normal |
| Aug 12, 2024 | Horse | Horse (unknown) | Ponazuril | Lack of efficacy - NOS | Outcome Unknown |
| Aug 10, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site swelling | Ongoing |
| Aug 9, 2024 | Horse | Warmblood - Dutch | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 9, 2024 | Horse | Quarter Horse | Firocoxib | Sunburn; Itching; Erythema (for urticaria see Immune SOC) | Recovered/Normal |
| Aug 8, 2024 | Horse | Holsteiner | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 8, 2024 | Horse | Horse (unknown) | Pentosan Polysulfate Sodium | Limb non-weight bearing; Limping | Ongoing |
| Aug 8, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 8, 2024 | Horse | Barb | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Aug 8, 2024 | Horse | Trakehner | Omeprazole | Lack of efficacy (protozoa) - Coccidia | Outcome Unknown |
| Aug 7, 2024 | Horse | Paint | Pergolide Mesylate | Lethargy (see also Central nervous system depression in Neurological) | Outcome Unknown |
| Aug 6, 2024 | Horse | Paint | Firocoxib | Abdominal oedema; Anorexia; Abnormal serum protein NOS; Other abnormal test r... | Euthanized |
| Aug 3, 2024 | Horse | Quarter Horse | Oclacitinib Maleate | Colic; Death by euthanasia | Euthanized |
| Aug 2, 2024 | Horse | Przewalski | Altrenogest Oily Solution | Lack of efficacy - NOS | Ongoing |
| Aug 2, 2024 | Horse | Thoroughbred | Pentosan Polysulfate Sodium | Hives (see also Skin) | Recovered/Normal |
| Aug 1, 2024 | Horse | Horse (unknown) | Xylazine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Aug 1, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Aug 1, 2024 | Horse | Pony (unspecified) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Aug 1, 2024 | Horse | Morgan | Pentosan Polysulfate Sodium | Injection site alopecia; Injection site hair change | Outcome Unknown |
| Aug 1, 2024 | Horse | Hackney | Pergolide Mesylate | Weight loss; Abnormal oestrus NOS | Outcome Unknown |
| Jul 30, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.